Primary Record
112811-57-1
- In stock
- 7,068 g
- Purity
- 98.3 %
- CAS
- 112811-57-1
Compound Identifiers & Properties
- CAS
- 112811-57-1
- PubChem CID
- 465562
- SMILES
- COC1=C2C(=CC(=C1N3CCNCC3)F)C(=O)C(=CN2C4CC4)C(=O)O
- Canonical SMILES
- COc1c(N2CCNCC2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12
Names & Synonyms
- 112811-57-1
- 1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
- Desmethyl Gatifloxacin
- 3-Desmethyl Gatifloxacin
- Quinolone der.
- 8-methoxyciprofloxacin
- BOB2CYB4VW
- UNII-BOB2CYB4VW
- 3-DesmethylGatifloxacin-d8
- AC1LABV5
- RefChem:170531
- 3-Desmethyl Gatifloxacin-d8
- ACMC-20mh18
- C18H20FN3O4
- MFCD25973505
- PD 135042
- CHEMBL14937
- Gatifloxacin USP Impurity D
- DTXSID70150187
- XJCSNIFKGXSDGN-UHFFFAOYSA-N
- Gatifloxacin Related Compound D
- SCHEMBL1155026
- DTXCID7072678
- PD135042
- CTK0H6056
- AM 1147
- UWC94153
- ZINC5853193
- CID465562
- AM-1147
- PD-135042
- 1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
- AJ-55064
- AS-76436
- SY271007
- AB0072337
- DB-363544
- J522.757G
- CS-0150509
- DESMETHYL GATIFLOXACIN [USP IMPURITY]
- FT-0666126
- ST24037974
- GATIFLOXACIN RELATED COMPOUND D [USP-RS]
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-7-(1-piperazinyl)-
- A894523
- GATIFOXACIN RELATED COMPOUND D [USP IMPURITY]
- 1794941-53-9
- Gatifloxacin Related Compound D(3-Desmethyl Gatifloxacin)
- 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid
- 1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylicacid
- 3-Quinolinecarboxylicacid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-7-(1-piperazinyl)-
- 1-Cyclopropyl-1,4-dihydro-4-oxo-6-fluoro-7-piperazino-8-methoxyquinoline-3-carboxylic acid
- 1-Cyclopropyl-6-fluoro-1,4-dihydro-7-piperazino-8-methoxy-4-oxoquinoline-3-carboxylic acid
- 1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
- 1-Cyclopropyl-4-oxo-6-fluoro-7-(1-piperazinyl)-8-methoxy-1,4-dihydro-3-quinolinecarboxylic acid
- 1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid
- 1-Cyclopropyl-6-fluoro-8-Methoxy-4-oxo-7-(piperazin-1-yl)1,4-dihydroquinoline-3-carboxylic acid
- 1-CYCLOPROPYL-6-FLUORO-8-METHOXY-4-OXO-7-(PIPERAZIN-1-YL)QUINOLINE-3-CARBOXYLIC ACID
- 1-cyclopropyl-6-fluoro-8-methoxy-7-(1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
- 1-cyclopropyl-6-fluoro-8-methoxy-7-(2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
- 1010883-86-9
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-7-(1-piperazinyl)-; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; AM 1147; PD 135042; 1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
- USP Gatifloxacin Related Compound D; 1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid